Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation

Human papillomavirus type 16 (HPV-16) is the major causative agent of cervical cancer. The life cycle of this oncogenic DNA tumour virus is strictly associated with the differentiation program of the infected epithelial cells. Expression of the viral capsid genes L1 and L2 can only be detected in th...

Full description

Bibliographic Details
Main Author: Zhao, Xiaomin
Format: Doctoral Thesis
Language:English
Published: Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi 2005
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5919
http://nbn-resolving.de/urn:isbn:91-554-6328-2
id ndltd-UPSALLA1-oai-DiVA.org-uu-5919
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-59192013-09-21T04:32:28ZRegulation of Human Papillomavirus Type 16 mRNA Splicing and PolyadenylationengZhao, XiaominUppsala universitet, Institutionen för medicinsk biokemi och mikrobiologiUppsala : Institutionen för medicinsk biokemi och mikrobiologi2005Medical scienceshuman papillomavirus type 16gene regulationsplicingpolyadenylation3' UTRMEDICIN OCH VÅRDMEDICINEMEDICINHuman papillomavirus type 16 (HPV-16) is the major causative agent of cervical cancer. The life cycle of this oncogenic DNA tumour virus is strictly associated with the differentiation program of the infected epithelial cells. Expression of the viral capsid genes L1 and L2 can only be detected in the terminally differentiated epithelial cells. The studies here focus on the regulation of HPV-16 late gene expression, which is under tight regulation. Our experimental system consisted of almost the full length HPV-16 genome driven by a strong CMV promoter. This plasmid and mutants thereof could be transfected into HeLa cells and RNA levels monitored. Using this system, we identified an hnRNP A1-dependent splicing silencer between positions 178 and 226 of the L1 gene. This silencer inhibited the use of the 3' splice site, located immediately upstream of the L1 AUG. We speculate that this splicing silencer plays an essential role in preventing late gene expression at an early stage of the viral life cycle. We subsequently identified a splicing enhancer located in the first 17 nucleotides of L1 that may be needed to counteract the multiple hnRNP A1 dependent splicing silencers in the L1 coding region. A 55kDa protein specifically bound to this splicing enhancer. We also demonstrated that binding of the cellular factors to the splicing silencer in the L1 coding region had an inhibitory effect on expression from L1 cDNA expression plasmids. The HPV-16 genome is divided into the early region and the late region, separated by the early poly(A) signal (pAE). pAE is used preferentially early in infection, thereby efficiently blocking late gene expression. We demonstrated that a 57 nucleotide U-rich region of the early 3’untranslated region (3’eUTR) acted as an enhancing upstream element on the usage of pAE. We demonstrated that this U-rich region specifically interacts with hFip1, CstF-64, hnRNP C1/C2 and PTB, suggesting that these factors were either enhancing or regulating polyadenylation at the HPV-16 pAE. In conclusion, two regulatory RNA elements that both act to prevent late gene expression at an early stage in the viral life cycle and in proliferating cells were identified: a splicing silencer in the late region and an upstream u-rich element at the pAE. Doctoral thesis, comprehensive summaryinfo:eu-repo/semantics/doctoralThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5919urn:isbn:91-554-6328-2Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1651-6206 ; 67application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Doctoral Thesis
sources NDLTD
topic Medical sciences
human papillomavirus type 16
gene regulation
splicing
polyadenylation
3' UTR
MEDICIN OCH VÅRD
MEDICINE
MEDICIN
spellingShingle Medical sciences
human papillomavirus type 16
gene regulation
splicing
polyadenylation
3' UTR
MEDICIN OCH VÅRD
MEDICINE
MEDICIN
Zhao, Xiaomin
Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation
description Human papillomavirus type 16 (HPV-16) is the major causative agent of cervical cancer. The life cycle of this oncogenic DNA tumour virus is strictly associated with the differentiation program of the infected epithelial cells. Expression of the viral capsid genes L1 and L2 can only be detected in the terminally differentiated epithelial cells. The studies here focus on the regulation of HPV-16 late gene expression, which is under tight regulation. Our experimental system consisted of almost the full length HPV-16 genome driven by a strong CMV promoter. This plasmid and mutants thereof could be transfected into HeLa cells and RNA levels monitored. Using this system, we identified an hnRNP A1-dependent splicing silencer between positions 178 and 226 of the L1 gene. This silencer inhibited the use of the 3' splice site, located immediately upstream of the L1 AUG. We speculate that this splicing silencer plays an essential role in preventing late gene expression at an early stage of the viral life cycle. We subsequently identified a splicing enhancer located in the first 17 nucleotides of L1 that may be needed to counteract the multiple hnRNP A1 dependent splicing silencers in the L1 coding region. A 55kDa protein specifically bound to this splicing enhancer. We also demonstrated that binding of the cellular factors to the splicing silencer in the L1 coding region had an inhibitory effect on expression from L1 cDNA expression plasmids. The HPV-16 genome is divided into the early region and the late region, separated by the early poly(A) signal (pAE). pAE is used preferentially early in infection, thereby efficiently blocking late gene expression. We demonstrated that a 57 nucleotide U-rich region of the early 3’untranslated region (3’eUTR) acted as an enhancing upstream element on the usage of pAE. We demonstrated that this U-rich region specifically interacts with hFip1, CstF-64, hnRNP C1/C2 and PTB, suggesting that these factors were either enhancing or regulating polyadenylation at the HPV-16 pAE. In conclusion, two regulatory RNA elements that both act to prevent late gene expression at an early stage in the viral life cycle and in proliferating cells were identified: a splicing silencer in the late region and an upstream u-rich element at the pAE.
author Zhao, Xiaomin
author_facet Zhao, Xiaomin
author_sort Zhao, Xiaomin
title Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation
title_short Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation
title_full Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation
title_fullStr Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation
title_full_unstemmed Regulation of Human Papillomavirus Type 16 mRNA Splicing and Polyadenylation
title_sort regulation of human papillomavirus type 16 mrna splicing and polyadenylation
publisher Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi
publishDate 2005
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5919
http://nbn-resolving.de/urn:isbn:91-554-6328-2
work_keys_str_mv AT zhaoxiaomin regulationofhumanpapillomavirustype16mrnasplicingandpolyadenylation
_version_ 1716597781199585280